Literature DB >> 15475488

Influence of sildenafil on gastric sensorimotor function in humans.

Giovanni Sarnelli1, Daniel Sifrim, Jozef Janssens, Jan Tack.   

Abstract

After a meal, the proximal stomach relaxes probably through the activation of nitrergic neurons in the gastric wall. Nitric oxide-induced smooth muscle relaxation involves activation of soluble guanylate cyclase, with cGMP production, which is then degradated by phosphodiesterase-5 (PDE-5). The aim of this study was to investigate the effect of sildenafil, a selective PDE-5 inhibitor, on fasting and postprandial proximal gastric volume and on gastric emptying rates in humans. A gastric barostat was used to study gastric compliance and perception to isobaric distension in healthy subjects before and after placebo (n = 13) or sildenafil, 50 mg (n = 15). In 10 healthy subjects, two gastric barostat studies were performed in randomized order to study the effect of placebo or sildenafil on postprandial gastric relaxation. Similarly, solid and liquid gastric emptying rates were studied in 12 healthy subjects. Sildenafil significantly increased fasting intragastric volume (141 +/- 15 vs. 163 +/- 15 ml, P < 0.05) and volumes of first perception. Sildenafil induced a higher and prolonged gastric relaxation either at 30 min (357 +/- 38 vs. 253 +/- 42 ml, P < 0.05) or 60 min (348 +/- 49 vs. 247 +/- 38 ml, P < 0.05) after the meal. Sildenafil did not alter solid half-emptying time but significantly delayed liquid emptying (43 +/- 4 vs. 56 +/- 4 min, P < 0.01). In conclusion, sildenafil significantly increases postprandial gastric volume and slows liquid emptying rate, confirming that meal-induced accommodation in humans involves the activation of a nitrergic pathway. The effect of sildenafil on gastric fundus suggests a therapeutic potential for phosphodiesterase inhibitors in patients with impaired gastric accommodation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475488     DOI: 10.1152/ajpgi.00419.2003

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  17 in total

1.  Functional dyspepsia.

Authors:  Rita Brun; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

Review 2.  Gastrointestinal motility in acute illness.

Authors:  Sonja Fruhwald; Peter Holzer; Helfried Metzler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 3.  Gastroparesis: current diagnostic challenges and management considerations.

Authors:  Shamaila Waseem; Baharak Moshiree; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 4.  Early satiety in cancer patients: a common and important but underrecognized symptom.

Authors:  Mellar P Davis; Declan Walsh; Ruth Lagman; Tugba Yavuzsen
Journal:  Support Care Cancer       Date:  2006-04-20       Impact factor: 3.603

5.  Idiopathic Dyspepsia.

Authors:  Vincenzo Stanghellini; Elisabetta Poluzzi; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Roberto Corinaldesi
Journal:  Curr Treat Options Gastroenterol       Date:  2005-04

Review 6.  Gender bias in gastroparesis: is nitric oxide the answer?

Authors:  P R R Gangula; K R Sekhar; S Mukhopadhyay
Journal:  Dig Dis Sci       Date:  2011-05-11       Impact factor: 3.199

7.  Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.

Authors:  Gwen Vanneste; Ingeborg Dhaese; Patrick Sips; Emmanuel Buys; Peter Brouckaert; Romain A Lefebvre
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

8.  Proximal Gastric Dysfunction in Functional Dyspepsia: Management Options.

Authors:  Jan Tack
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08

9.  Current treatments in functional dyspepsia.

Authors:  Meredythe A McNally; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04

10.  Prevalence and determinants of delayed gastric emptying in hospitalised Type 2 diabetic patients.

Authors:  Vladimir Kojecky; Jaromir Bernatek; Michael Horowitz; Stanislav Zemek; Jiri Bakala; Ales Hep
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.